Literature DB >> 9174560

Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis.

N P Robertson1, J I O'Riordan, J Chataway, D P Kingsley, D H Miller, D Clayton, D A Compston.   

Abstract

BACKGROUND: There has been no previous systematic study of conjugal multiple sclerosis. This study of conjugal pairs with complex traits investigated disease transmissibility and the genetic contribution to frequency and clinical course.
METHODS: We studied 45 conjugal pairs concordant for multiple sclerosis from 58 pairs recorded in a national register of familial disease, 86 offspring of the 45 pairs were individually assessed for clinical evidence of neurological disease; those over age 16 underwent cranial magnetic resonance imaging. Clinical features were compared in 33 pairs in whom neither member had symptoms before they met.
FINDINGS: Of the 86 offspring, five (6%) had clinically definite multiple sclerosis. A further five children had either characteristic imaging abnormalities or clinical symptoms consistent with demyelination, but did not meet the criteria for clinically definite disease. There was no evidence of clinical concordance, clustering at year of onset, or distortion of the expected pattern of age of onset in the second affected spouse from 33 pairs. The crude recurrence in children of conjugal pairs (1 in 17) is significantly higher than previously reported population-based risk for offspring of single affected parents (1 in 200).
INTERPRETATION: Taken with the low prevalence of multiple sclerosis in the spouses of affected individuals, and the lack of concordance for age at onset in these families, the disparity in crude recurrence between children of conjugal pairs and those of single affected parents shows that the recurrence risk in children is determined by genetic factors inherited from both parents.

Entities:  

Mesh:

Year:  1997        PMID: 9174560     DOI: 10.1016/s0140-6736(96)07317-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

Review 1.  Genetic analysis of multiple sclerosis.

Authors:  Alastair Compston; Stephen Sawcer
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

2.  A high-density screen for linkage in multiple sclerosis.

Authors:  Stephen Sawcer; Maria Ban; Mel Maranian; Tai Wai Yeo; Alastair Compston; Andrew Kirby; Mark J Daly; Philip L De Jager; Emily Walsh; Eric S Lander; John D Rioux; David A Hafler; Adrian Ivinson; Jacqueline Rimmler; Simon G Gregory; Silke Schmidt; Margaret A Pericak-Vance; Eva Akesson; Jan Hillert; Pameli Datta; Annette Oturai; Lars P Ryder; Hanne F Harbo; Anne Spurkland; Kjell-Morten Myhr; Mikko Laaksonen; David Booth; Robert Heard; Graeme Stewart; Robin Lincoln; Lisa F Barcellos; Stephen L Hauser; Jorge R Oksenberg; Shannon J Kenealy; Jonathan L Haines
Journal:  Am J Hum Genet       Date:  2005-07-29       Impact factor: 11.025

3.  Mitochondrial mutation in Iranian patients with multiple sclerosis, correlation between haplogroups H, A and clinical manifestations.

Authors:  Mojdeh Ghabaee; Motahar Omranisikaroudi; Shahla Amrisaroukolaei; Alipasha Meysamie; Mohammad Ali Sahraian; Asghar Bayati; Mohammad Hossein Sanati; Mossoud Houshman; Homa Sadeghian; Khalili Vajihazaman
Journal:  Cell Mol Neurobiol       Date:  2008-11-14       Impact factor: 5.046

4.  The genetic aspects of multiple sclerosis.

Authors:  Stephen Sawcer
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

5.  Multiple sclerosis in sibling pairs: an analysis of 250 families.

Authors:  J Chataway; A Mander; N Robertson; S Sawcer; J Deans; M Fraser; S Broadley; D Clayton; A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

6.  Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.

Authors:  D R Booth; A T Arthur; S M Teutsch; C Bye; J Rubio; P J Armati; J D Pollard; R N S Heard; G J Stewart
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

7.  Stressed cybrids model demyelinated axons in multiple sclerosis.

Authors:  Laura Llobet; Aurora Gómez-Durán; Ruth Iceta; Eldris Iglesias; Julio Montoya; Jesús Martín-Martínez; José Ramón Ara; Eduardo Ruiz-Pesini
Journal:  Metab Brain Dis       Date:  2013-04-24       Impact factor: 3.584

Review 8.  The cost of multiple sclerosis and the cost effectiveness of disease-modifying agents in its treatment.

Authors:  Ceri J Phillips
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 9.  Multiple sclerosis.

Authors:  David A Hafler
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

10.  Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.

Authors:  Derya Kaya; Egemen Idiman; Serkan Ozakbaş
Journal:  Autoimmune Dis       Date:  2012-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.